| Literature DB >> 11799593 |
.
Abstract
Sibutramine (Reductil-Abbott Laboratories), an orally active monoamine re-uptake inhibitor, is marketed in the UK for treating overweight adults. The company claims that it "helps obese patients control their eating". Is the drug worth prescribing?Entities:
Mesh：
Substances：
Year: 2001 PMID： 11799593 DOI： 10.1136/dtb.2001.391289
Source DB: PubMed Journal: Drug Ther Bull ISSN： 0012-6543